View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Martin Arnell
  • Martin Arnell

MTG (Buy, TP: SEK130.00) - Encouraging organic growth trend

MTG’s 2025 organic growth outlook of 3–7% YOY was a key positive in an otherwise difficult market for mobile gaming, in our view. However, the adj. EBITDA margin guidance of 21–24% fell shy of our expectation. We have only finetuned our 2025–2026e sales, but cut adj. EBITDA by 18–7% on the margin outlook, with some upside potential if synergies from the Plarium acquisition should materialise in 2025. We reiterate our BUY, but have lowered our target price to SEK130 (140).

Niclas Gehin
  • Niclas Gehin

Norsk Hydro (Sell, TP: NOK55.00) - Q1 shipments delayed to Q2

Norsk Hydro’s Q1 results fell somewhat short of market expectations (EBITDA 4% below consensus) and it cut its Extrusions guidance. A large share of the miss appears to reflect late shipments in the bauxite and alumina (B&A) segment following heavy rainfall, which should mean higher volumes in Q2. We have made only minor changes (-1–0%) to our 2026–2027e EPS. We continue to see downside risk to aluminium prices, and reiterate our SELL and NOK55 target price.

ABGSC Metals & Mining Research ... (+3)
  • ABGSC Metals & Mining Research
  • Bengt Jonassen
  • Martin Melbye
ABGSC Metals & Mining Research ... (+3)
  • ABGSC Metals & Mining Research
  • Bengt Jonassen
  • Martin Melbye
 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

ABGSC Metals & Mining Research ... (+3)
  • ABGSC Metals & Mining Research
  • Bengt Jonassen
  • Martin Melbye
Johannes Grunselius
  • Johannes Grunselius

UPM (Buy, TP: EUR36.00) - Solid entry points into quality

Following the solid Q1 report that was supported by the low-cost pulp operations in Uruguay, we have kept our optimistic 2025–2027e earnings, translating into highly attractive valuation multiples largely unchanged. With heavily reduced capex set for the coming years, we also still forecast strong cash flows, leaving the balance sheet overcapitalised. With this backdrop, we believe UPM will continue to pursue buybacks on top of compelling dividends in most feasible scenarios. We reiterate our BU...

ABGSC Pulp & Paper Research ... (+4)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
 PRESS RELEASE

Andrew Taylor joins Novonesis’ Executive Leadership Team

Andrew Taylor joins Novonesis’ Executive Leadership Team Andrew Taylor will assume the role as EVP of Food & Beverage Biosolutions at Novonesis. Please read the full announcement in PDF. Attachment

 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

Martin Arnell
  • Martin Arnell

MTG (Buy, TP: SEK140.00) - First quarter including Plarium

Q1 will be the first quarter including the transformative Plarium acquisition (consolidated from 1 February), set to roughly double MTG’s revenue and adj. EBITDA. Our impression is organic growth trends have held up alright in Q1; however, the recent strengthening of the SEK has prompted a ~9% cut to our 2025–2026e revenue and EBITDA. We have lowered our target price to SEK140 (150) but reiterate our BUY.

 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

ABGSC Metals & Mining Research ... (+3)
  • ABGSC Metals & Mining Research
  • Bengt Jonassen
  • Martin Melbye
 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Ali Shemmari
  • Martin Melbye
 PRESS RELEASE

Resolutions from the Annual General Meeting 2025

Resolutions from the Annual General Meeting 2025 Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted.  The following resolutions were made: Approval of the audited Annual Report for 2024Approval of distribution of profit with payment of an ordinary dividend of DKK 4.20 (corresponding to approximately EUR 0.56) per A and B share. In addition to this year-end dividend, an interim dividend of DKK 2.00 (EUR ~0.27) was disbursed on September 3, 2024.Approval of the Remuneration Report for 2024 (advisory vote)Approval of the remuneration of members of the Board of Direc...

Johannes Grunselius
  • Johannes Grunselius

UPM (Buy, TP: EUR36.00) - Separating the wheat from the chaff

While acknowledging the overall high macro uncertainty, we still expect UPM to show continued earnings growth in 2025, in contrast to many other cyclical companies. Due to a more cautious view on pulp prices and FX, we have cut our 2025–2026e EBITDA by 12–8%. Still, our earnings scenario remains highly attractive. We have also lowered our 2026–2027e capex as we believe the company will push growth investments into the future and instead prioritise share buybacks. We reiterate our BUY, but have c...

 PRESS RELEASE

Transactions under Novonesis’ share buyback program

Transactions under Novonesis’ share buyback program Please read the announcement in PDF Attachment

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch